A detailed history of Manchester Capital Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 74 shares of CRL stock, worth $13,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74
Previous 24 208.33%
Holding current value
$13,772
Previous $4,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$187.96 - $245.29 $9,398 - $12,264
50 Added 208.33%
74 $14,000
Q2 2024

Aug 08, 2024

BUY
$206.39 - $268.73 $4,953 - $6,449
24 New
24 $4,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $16,768 - $20,623
-45 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $13,237 - $16,724
45 New
45 $17,000
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $749 - $898
-3 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $666 - $757
3 New
3 $1,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.